ABCSG https://www.abcsg.org/en/ Austrian Breast & Colorectal Cancer Study Group Mon, 18 May 2026 06:42:35 +0000 en-US hourly 1 ABCSG Annual Report 2025 now available online! https://www.abcsg.org/en/abcsg-annual-report-2025-now-available-online/ Mon, 18 May 2026 06:38:28 +0000 https://www.abcsg.org/?p=41459 ABCSG Jahresbericht 2025

We are pleased to share the ABCSG Annual Report 2025. It provides an overview of an exceptionally successful and highly productive year for the ABCSG. With 30 publications in internationally renowned peer-reviewed journals, 2025 marked the most impactful publication year in ABCSG history. We were also able to initiate several new innovative clinical trials and […]

Source

]]> Editorial by Professor Michael Gnant published in Cancer Biology & Medicine https://www.abcsg.org/en/editorial-von-prof-michael-gnant-in-cancer-biology-medicine-veroeffentlicht/ Wed, 15 Apr 2026 09:48:02 +0000 https://www.abcsg.org/editorial-von-prof-michael-gnant-in-cancer-biology-medicine-veroeffentlicht/ Editorial by Professor Michael Gnant published in Cancer Biology & Medicine

We are pleased to share a recent editorial by ABCSG President Professor Michael Gnant, who was invited to present his assessments on the evolving landscape of breast cancer care in Cancer Biology & Medicine. Under the title “Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, […]

Source

]]> International Profile: CancerWorld Honors Prof. Michael Gnant https://www.abcsg.org/en/internationales-portraet-cancerworld-wuerdigt-prof-michael-gnant/ Tue, 10 Mar 2026 14:13:48 +0000 https://www.abcsg.org/internationales-portraet-cancerworld-wuerdigt-prof-michael-gnant/ CancerWorld würdigt Prof. Michael Gnant

CancerWorld, published by OncoDaily, features ABCSG-president Michael Gnant in its latest issue, highlighting his influential contribution to modern breast cancer research and treatment. The article portrays a physician-scientist who has repeatedly challenged established routines and encouraged critical thinking in clinical practice. Special attention is also given to the development of ABCSG, which has evolved from […]

Source

]]> Joyful Festive Season https://www.abcsg.org/en/joyful-festive-season-2/ Tue, 23 Dec 2025 04:00:06 +0000 https://www.abcsg.org/?p=40766 Joyful Festive Season 2025

The ABCSG wishes you and your loved ones a peaceful festive season and a healthy, successful New Year. May the coming year bring confidence, positive encounters, and continued progress — both personally and professionally. Thank you for your trust, your engagement, and the valuable collaboration throughout the year.

Source

]]> 20 years at the helm of ABCSG: https://www.abcsg.org/en/20-years-at-the-helm-of-abcsg/ Sat, 15 Nov 2025 16:59:41 +0000 https://www.abcsg.org/?p=40304 20 Jahre an der Spitze der ABCSG

At this year’s ABCSG Annual Meeting, Professor Michael Gnant was honored for his 20 years of pioneering work as President of the ABCSG. The tribute took place in the presence of numerous colleagues who emphasized his continuous dedication and his significant contribution to advancing clinical cancer research in Austria. A special highlight of the evening […]

Source

]]> ABCSG 67N / CAROLEEN study: First Patient Enrolled https://www.abcsg.org/en/abcsg-67n-caroleen-study-first-patient-enrolled/ Thu, 30 Oct 2025 14:23:39 +0000 https://www.abcsg.org/?p=40181 ABCSG 67N / CAROLEEN

The ABCSG is pleased to announce that the first patient from Austria has been enrolled in the ABCSG 67N / CAROLEEN at Sanatorium Hera under the leadership of PI Yelena Devyatko. We warmly congratulate PI Yelena Devyatko and the dedicated team in Sanatorium Hera on this important first milestone. ABCSG 67N / CAROLEEN is a […]

Source

]]> ABCSG 65 / DEFINITIVE: First patient randomized https://www.abcsg.org/en/abcsg-65-definitive-first-patient-randomized/ Thu, 09 Oct 2025 09:41:58 +0000 https://www.abcsg.org/?p=39865 Study Design: ABCSG 65 The ABCSG is proud to report that the first Austrian patient has been randomized in the ABCSG 65 / DEFINITIVE trial at LKH Hochsteiermark, site Leoben, under the lead of PI Dr. Thamer Sliwa. Congratulations to Dr. Sliwa and his dedicated team in Leoben on achieving this important milestone.

The ABCSG is proud to report that the first Austrian patient has been randomized in the ABCSG 65 / DEFINITIVE trial at LKH Hochsteiermark, site Leoben, under the lead of PI Dr. Thamer Sliwa. Congratulations to Dr. Sliwa and his dedicated team in Leoben on achieving this important milestone. ABCSG 65 / DEFINITIVE (Diagnostic HER2DX-guided […]

Source

]]> ABCSG 61 / TEODOR: First Patient Registered in the Run-in Phase https://www.abcsg.org/en/abcsg-61-teodor-first-patient-registered-in-the-run-in-phase/ Thu, 14 Aug 2025 09:23:35 +0000 https://www.abcsg.org/?p=39193 ABCSG 61 Studiendesign

The ABCSG is pleased to announce another important milestone in the national phase II study ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness). Under the coordination of Dr. Daniel Egle, the first patient was registered in the run-in phase at the Breast Health Center of the Department of Obstetrics and […]

Source

]]> ABCSG 61 / TEODOR: First center opened for patient enrollment https://www.abcsg.org/en/abcsg-61-teodor-first-center-opened-for-patient-enrollment/ Wed, 30 Jul 2025 03:00:00 +0000 https://www.abcsg.org/?p=39018 ABCSG 61 / TEODOR

The new ABCSG study ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness) has launched with the activation of its first site – the Center for Breast Health in the Department of Gynecology at the Medical University of Vienna, headed by Prof. Christian Singer. TEODOR is dedicated to optimizing neoadjuvant treatment […]

Source

]]> CDK4/6 Inhibition in Early and Advanced Breast Cancer 2025 https://www.abcsg.org/en/cdk4-6-webinar-2025/ Sat, 28 Jun 2025 04:00:56 +0000 https://www.abcsg.org/cdk4-6-webinar-2025/ CDK4/6 Inhibition in Early and Advanced Breast Cancer 2025

We invite you to join the upcoming ABCSG webinar dedicated to the evolving role of CDK4/6 inhibitors in the treatment of hormone receptor-positive (HR+) breast cancer. This year’s session will explore both metastatic and early-stage settings, with a focus on recent trial results, clinical controversies, and practical decision-making. The event will open with a dynamic […]

Source

]]> ABCSG Featured in BIG Annual Report 2024 https://www.abcsg.org/en/abcsg-im-big-jahresbericht-2024-vertreten/ Sat, 28 Jun 2025 03:55:58 +0000 https://www.abcsg.org/abcsg-im-big-jahresbericht-2024-vertreten/ BIG-Jahresbericht

The ABCSG is once again featured in the Breast International Group’s (BIG) Annual Report, which highlights the breadth of our activities and achievements throughout 2024. The article reflects on our scientific progress amid global challenges, ABCSG’s international visibility through publications and congress presentations, operational advancements in international clinical research, and our strong commitment to education […]

Source

]]> Congratulations to Dominik Hlauschek on His First Full Publication in ESMO Open! https://www.abcsg.org/en/wir-gratulieren-unserem-statistiker-dominik-hlauschek-zu-seiner-ersten-wissenschaftlichen-vollpublikation-in-esmo-open/ Fri, 13 Jun 2025 03:50:51 +0000 https://www.abcsg.org/wir-gratulieren-unserem-statistiker-dominik-hlauschek-zu-seiner-ersten-wissenschaftlichen-vollpublikation-in-esmo-open/ The impact of analysis methodology details on invasive breast cancer-free survival in randomized clinical trials

A proud moment for the ABCSG statistics team: our colleague Dominik Hlauschek has just published his first full paper in ESMO Open — a key step in his scientific career. Congratulations – and many thanks to Christian Fesl for his leadership and to the whole statistics team for their support! This paper critically examines the […]

Source

]]> Editorial by ABCSG President Prof. Gnant in the British Journal of Surgery on the future of surgical research https://www.abcsg.org/en/editorial-von-abcsg-praesident-prof-gnant-im-british-journal-of-surgery-zur-zukunft-der-chirurgischen-forschung/ Wed, 04 Jun 2025 13:39:04 +0000 https://www.abcsg.org/editorial-von-abcsg-praesident-prof-gnant-im-british-journal-of-surgery-zur-zukunft-der-chirurgischen-forschung/ British Journal of Surgery

ABCSG President Prof. Michael Gnant has published an editorial in the British Journal of Surgery “The future of surgical research” Oxford University Press, Volume 112, Issue 6, 03. Juni 2025 https://doi.org/10.1093/bjs/znaf095 In this editorial, he reflects on the pressures currently facing academic surgery – ranging from limited resources to the challenge of placing greater value […]

Source

]]> ABCSG Annual Report 2024 now available online! https://www.abcsg.org/en/abcsg-jahresbericht-2024-jetzt-online-verfuegbar/ Tue, 27 May 2025 09:20:53 +0000 https://www.abcsg.org/abcsg-jahresbericht-2024-jetzt-online-verfuegbar/ ABCSG Jahresbericht 2024

We’re excited to share the 2024 ABCSG Annual Report with you. It offers an in-depth and accessible look at our accomplishments over the past year. Inside, you’ll find updates on our clinical trials for breast, colorectal, and pancreatic cancers; insights into our growing translational research efforts; highlights from our educational initiatives; and a selection of […]

Source

]]> Vienna School of Clinical Research VSCR https://www.abcsg.org/en/vienna-school-of-clinical-research-vscr/ Tue, 06 May 2025 14:47:00 +0000 https://www.abcsg.org/?p=35743 VSCR

Since its foundation in the year 2000 the Vienna School of Clinical Research VSCR has focused on training and education in all relevant topics in Clinical Research. VSCR is currently offering 14 online short courses which cover all essential categories to design, plan, approve, execute, monitor, inspect and evaluate/report clinical trials. The courses are offered […]

Source

]]> PALLAS 2nd Call for Research Project Proposals https://www.abcsg.org/en/pallas-2nd-call-for-research-project-proposals/ Tue, 01 Apr 2025 10:28:39 +0000 https://www.abcsg.org/pallas-2nd-call-for-research-project-proposals/ PALLAS 2nd Call for Research Project Proposals

Per study design, the treatment phase in PALLAS is followed by an extensive follow-up Phase of 10 years, until 2028. Up until then, biological samples and patient data will continue to be collected and documented at pre-defined intervals. Available datasets and samples, in combination with data and samples to be documented in the future, build […]

Source

]]> Joyful Festive Season https://www.abcsg.org/en/joyful-festive-season/ Mon, 23 Dec 2024 04:19:58 +0000 https://www.abcsg.org/?p=37555 Frohe Festtage

The ABCSG sends you and your loved ones warm wishes for a joyful festive season and a prosperous New Year! May the year ahead bring you happiness, good health, and many positive moments.

Source

]]> Fighting Breast Cancer around the Globe https://www.abcsg.org/en/fighting-breast-cancer-around-the-globe/ Fri, 06 Dec 2024 10:42:23 +0000 https://www.abcsg.org/fighting-breast-cancer-around-the-globe/ BIG

Under the motto “25 Years of Progress for People with Breast Cancer,” the anniversary edition of the BIG Newsletter “Research in Focus” (Issue 21, November 2024) highlights the latest ABCSG projects and our innovative approaches to personalized breast cancer treatment. “The growing precision of breast cancer treatment, guided by biomarkers and molecular profiles, allows us […]

Source

]]> St. Gallen International Breast Cancer Conference 2025 https://www.abcsg.org/en/st-gallen-international-breast-cancer-conference-2025/ Mon, 02 Dec 2024 12:16:10 +0000 https://www.abcsg.org/st-gallen-international-breast-cancer-conference-2025/ SGBCC 2025

Join us as we follow our Conference Chair, Michael Gnant, through the venue of the 19th St. Gallen International Breast Cancer Conference in Vienna. While showing us around the Austria Center Vienna, he answered our top 10 questions regarding the “SGBCC 2025”. Standing on the same stage where the Consensus Meeting will be held, he […]

Source

]]> The on-demand video of the webinar “CDK4/6 Inhibition in Early and Advanced Breast Cancer – Recent data and controversies 2024“ is now available! https://www.abcsg.org/en/the-on-demand-video-of-the-webinar-cdk4-6-inhibition-in-early-and-advanced-breast-cancer-recent-data-and-controversies-2024-is-now-available/ Thu, 14 Nov 2024 16:15:33 +0000 https://www.abcsg.org/the-on-demand-video-of-the-webinar-cdk4-6-inhibition-in-early-and-advanced-breast-cancer-recent-data-and-controversies-2024-is-now-available/ webinar “CDK4/6 Inhibition in Early and Advanced Breast Cancer – Recent data and controversies 2024“ i

The virtual continuing education event “CDK4/6 Inhibition in Early and Advanced Breast Cancer – Recent Data and Controversies 2024” took place on Wednesday, October 30th, 2024, from 5:30 to 7:30 pm CET. A total of 116 participants from 15 countries joined the webinar, which was moderated by ABCSG President Michael Gnant. In Part 1, the […]

Source

]]>